| LLY |
Eli Lilly and Company |
711.61B |
18.53% |
|
|
|
|
|
749.60 |
-0.51% |
39.04% |
42.37% |
|---|
| AMGN |
Amgen Inc. |
155.83B |
6.48% |
|
|
|
|
|
289.90 |
0.71% |
51.85% |
92.17% |
|---|
| NVS |
Novartis AG |
203.16B |
6.48% |
|
|
|
|
|
103.84 |
0.73% |
20.44% |
36.17% |
|---|
| USBGFS7 |
US BANK MMDA - USBGFS 7 06/01/2031 |
|
6.03% |
|
|
|
|
|
|
|
|
|
|---|
| AZN |
AstraZeneca PLC |
199.24B |
5.73% |
|
|
|
|
|
64.26 |
1.68% |
28.17% |
62.73% |
|---|
| BMY |
Bristol-Myers Squibb Company |
118.11B |
5.69% |
|
|
|
|
|
58.24 |
0.61% |
23.40% |
18.97% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
31.83B |
5.01% |
|
|
|
|
|
246.80 |
-0.80% |
45.69% |
29.50% |
|---|
| JNJ |
Johnson & Johnson |
374.34B |
4.99% |
|
|
|
|
|
155.48 |
1.55% |
18.20% |
30.35% |
|---|
| PFE |
Pfizer Inc. |
142.44B |
4.50% |
|
|
|
|
|
25.14 |
0.78% |
30.01% |
69.40% |
|---|
| MRK |
Merck & Co., Inc. |
252.53B |
4.26% |
|
|
|
|
|
99.83 |
2.45% |
24.01% |
49.79% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
80.46B |
4.08% |
|
|
|
|
|
744.50 |
0.15% |
30.82% |
65.68% |
|---|
| ALKS |
Alkermes plc |
4.48B |
3.72% |
|
|
|
|
|
27.70 |
-0.75% |
36.13% |
55.87% |
|---|
| BIIB |
Biogen Inc. |
23.03B |
3.49% |
|
|
|
|
|
158.01 |
1.29% |
30.76% |
40.69% |
|---|
| CRSP |
CRISPR Therapeutics AG |
3.95B |
3.16% |
|
|
|
|
|
46.29 |
-2.05% |
57.71% |
24.82% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
5.36B |
3.03% |
|
|
|
|
|
33.94 |
-4.12% |
44.84% |
38.77% |
|---|
| GSK |
GSK plc |
68.71B |
2.63% |
|
|
|
|
|
33.69 |
1.02% |
23.99% |
58.65% |
|---|
| BCYC |
Bicycle Therapeutics plc |
1.40B |
2.15% |
|
|
|
|
|
20.26 |
-0.49% |
116.37% |
41.34% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
1.41B |
1.32% |
|
|
|
|
|
13.80 |
5.18% |
83.22% |
57.20% |
|---|
| BEAM |
Beam Therapeutics Inc. |
1.95B |
1.30% |
|
|
|
|
|
23.58 |
-3.72% |
81.03% |
71.39% |
|---|
| REPL |
Replimune Group, Inc. |
756.01M |
1.08% |
|
|
|
|
|
11.05 |
-1.60% |
78.14% |
3.47% |
|---|
| HLN |
Haleon plc |
43.25B |
0.85% |
|
|
|
|
|
9.56 |
0.79% |
62.50% |
18.86% |
|---|
| GALT |
Galectin Therapeutics Inc. |
170.71M |
0.84% |
|
|
|
|
|
2.7200 |
-3.37% |
308.93% |
103.10% |
|---|
| VNDA |
Vanda Pharmaceuticals Inc. |
288.04M |
0.74% |
|
|
|
|
|
4.94 |
0.82% |
68.29% |
31.00% |
|---|
| LTRN |
Lantern Pharma Inc. |
31.81M |
0.60% |
|
|
|
|
|
2.9500 |
0.34% |
211.94% |
58.49% |
|---|
| EDIT |
Editas Medicine, Inc. |
195.64M |
0.60% |
|
|
|
|
|
2.3700 |
-1.66% |
220.11% |
79.60% |
|---|
| SDZNY |
Sandoz Group AG |
|
0.52% |
|
|
|
|
|
|
|
|
|
|---|
| TSVT |
2seventy bio, Inc. |
162.73M |
0.51% |
|
|
|
|
|
3.16 |
1.61% |
158.50% |
21.48% |
|---|
| GEHC |
GE HealthCare Technologies Inc. |
37.46B |
0.50% |
|
|
|
|
|
82.00 |
-3.42% |
25.22% |
25.22% |
|---|
| ALLO |
Allogene Therapeutics, Inc. |
442.41M |
0.33% |
|
|
|
|
|
2.1100 |
2.93% |
369.60% |
57.86% |
|---|
| Cash&Other |
Cash & Other |
|
0.27% |
|
|
|
|
|
|
|
|
|
|---|
| VTRS |
Viatris Inc. |
15.82B |
0.26% |
|
|
|
|
|
13.25 |
0.91% |
32.48% |
9.75% |
|---|
| PACB |
Pacific Biosciences of California, Inc. |
484.74M |
0.15% |
|
|
|
|
|
1.7700 |
2.91% |
92.20% |
25.17% |
|---|
| BLUE |
bluebird bio, Inc. |
57.92M |
0.11% |
|
|
|
|
|
0.2979 |
-1.68% |
652.55% |
46.13% |
|---|
| MURA |
Mural Oncology plc |
57.42M |
0.05% |
|
|
|
|
|
3.37 |
0.00% |
244.34% |
21.30% |
|---|
| SLRX |
Salarius Pharmaceuticals, Inc. |
2.08M |
0.04% |
|
|
|
|
|
1.4400 |
2.86% |
N/A |
N/A |
|---|
| 2368714D |
Pathos AI Inc |
|
N/A |
|
|
|
|
|
|
|
|
|
|---|